Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis.
Luisa AgnelloMatteo VidaliRosaria Vincenza GiglioCaterina Maria GambinoAnna Maria CiaccioBruna Lo SassoMarcello CiaccioPublished in: Clinical chemistry and laboratory medicine (2022)
PHI has a high accuracy for detecting PCa and discriminating between aggressive and non-aggressive PCa. Thus, it could be useful as a biomarker in predicting patients harbouring more aggressive cancer and guiding biopsy decisions.